We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

106 hedge funds and large institutions have $159M invested in Surgalign Holdings, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 43 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less funds holding

Funds holding: 111106 (-5)

7% less capital invested

Capital invested by funds: $171M → $159M (-$12M)

17% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 12

21% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 43

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
106
Holders Change
-5
Holders Change %
-4.5%
% of All Funds
3.44%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
10
Increased
34
Reduced
43
Closed
12
Calls
$17K
Puts
Net Calls
+$17K
Net Calls Change
-$7K
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$1.23M +$60.8K +536 +5%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$1.13M +$169K +1,486 +17%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.1M -$88.8K -783 -7%
Goldman Sachs
29
Goldman Sachs
New York
$1.05M +$495K +4,363 +87%
TCIM
30
TIAA CREF Investment Management
New York
$998K -$73K -643 -7%
BCM
31
Bridgeway Capital Management
Texas
$839K +$321K +2,833 +61%
Charles Schwab
32
Charles Schwab
California
$836K -$129K -1,139 -13%
SO
33
STRS Ohio
Ohio
$802K +$144K +1,267 +22%
GF
34
Gabelli Funds
New York
$785K
BIM
35
BlackRock Investment Management
Delaware
$736K +$9.3K +82 +1%
NTCOC
36
Northern Trust Company of Connecticut
Connecticut
$663K -$171K -1,511 -20%
DCM
37
DAFNA Capital Management
California
$625K
Fidelity Investments
38
Fidelity Investments
Massachusetts
$615K -$2.95K -26 -0.5%
MCM
39
Munder Capital Management
Michigan
$603K +$362K +3,194 +147%
WFM
40
Wilmington Funds Management
Delaware
$589K
WCM
41
Wedge Capital Management
North Carolina
$558K +$120K +1,060 +27%
PPA
42
Parametric Portfolio Associates
Washington
$514K -$7.49K -66 -1%
AA
43
Ancora Advisors
Ohio
$484K +$37.9K +334 +8%
CS
44
Credit Suisse
Switzerland
$455K +$74K +652 +19%
Arrowstreet Capital
45
Arrowstreet Capital
Massachusetts
$450K
Two Sigma Investments
46
Two Sigma Investments
New York
$434K -$7.04K -62 -2%
Wells Fargo
47
Wells Fargo
California
$405K -$51.1K -450 -11%
Deutsche Bank
48
Deutsche Bank
Germany
$392K +$150K +1,320 +60%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$379K +$12.1K +107 +3%
BA
50
BlackRock Advisors
Delaware
$353K +$33.7K +297 +10%

SRGA Hedge Fund Activity: Q3 2013 in Review

106 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q3 2013, worth a combined $159M — down 7% from $171M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of SRGA and 10 opened new positions — a net loss of 2 holders — while 43 trimmed existing stakes and 34 added.

The largest buyer was Royce & Associates, adding an estimated $2.27M. The largest seller was Fort Washington Investment Advisors, cutting an estimated $3.25M.

  • 106 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q3 2013, down from 111 in Q2 2013.
  • Funds reported $159M of Surgalign Holdings, Inc. Common Stock stock for Q3 2013, down 7% quarter-over-quarter.
  • 10 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q3 2013 and 12 closed out, a net change of -2 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q3 2013 was Royce & Associates, an estimated $2.27M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q3 2013 was Fort Washington Investment Advisors, an estimated $3.25M sold.

Based on aggregated 13F filings for Q3 2013.